Belgium
· Delayed Price · Currency is EUR Sequana Medical NV Statistics
Total Valuation
Sequana Medical NV has a market cap or net worth of EUR 33.95 million. The enterprise value is 52.13 million.
| Market Cap | 33.95M |
| Enterprise Value | 52.13M |
Important Dates
The last earnings date was Friday, December 13, 2024.
| Earnings Date | Dec 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Sequana Medical NV has 44.44 million shares outstanding. The number of shares has increased by 23.48% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 44.44M |
| Shares Change (YoY) | +23.48% |
| Shares Change (QoQ) | +14.56% |
| Owned by Insiders (%) | 9.36% |
| Owned by Institutions (%) | 28.65% |
| Float | 26.52M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 53.40 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.92 |
| EV / Sales | 120.25 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -2.03 |
Financial Position
The company has a current ratio of 0.41
| Current Ratio | 0.41 |
| Quick Ratio | 0.26 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.87 |
| Interest Coverage | -5.39 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -82.38% |
| Return on Capital (ROIC) | -176.06% |
| Revenue Per Employee | 6,992 |
| Profits Per Employee | -438,381 |
| Employee Count | 62 |
| Asset Turnover | 0.02 |
| Inventory Turnover | 0.04 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -82.10% in the last 52 weeks. The beta is 0.84, so Sequana Medical NV's price volatility has been lower than the market average.
| Beta (5Y) | 0.84 |
| 52-Week Price Change | -82.10% |
| 50-Day Moving Average | 0.84 |
| 200-Day Moving Average | 1.18 |
| Relative Strength Index (RSI) | 49.19 |
| Average Volume (20 Days) | 145,057 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sequana Medical NV had revenue of EUR 433,500 and -27.18 million in losses. Loss per share was -0.90.
| Revenue | 433,500 |
| Gross Profit | 331,759 |
| Operating Income | -23.67M |
| Pretax Income | -26.82M |
| Net Income | -27.18M |
| EBITDA | -23.32M |
| EBIT | -23.67M |
| Loss Per Share | -0.90 |
Balance Sheet
The company has 4.15 million in cash and 22.33 million in debt, giving a net cash position of -18.18 million or -0.41 per share.
| Cash & Cash Equivalents | 4.15M |
| Total Debt | 22.33M |
| Net Cash | -18.18M |
| Net Cash Per Share | -0.41 |
| Equity (Book Value) | -19.56M |
| Book Value Per Share | -0.54 |
| Working Capital | -10.31M |
Cash Flow
In the last 12 months, operating cash flow was -25.06 million and capital expenditures -658,700, giving a free cash flow of -25.72 million.
| Operating Cash Flow | -25.06M |
| Capital Expenditures | -658,700 |
| Free Cash Flow | -25.72M |
| FCF Per Share | -0.58 |
Margins
| Gross Margin | 76.53% |
| Operating Margin | -5,460.09% |
| Pretax Margin | -6,187.68% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Sequana Medical NV does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -23.48% |
| Shareholder Yield | -23.48% |
| Earnings Yield | -117.43% |
| FCF Yield | -75.75% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Sequana Medical NV has an Altman Z-Score of -35. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -35 |
| Piotroski F-Score | n/a |